Mode
Text Size
Log in / Sign up

Colorectal Cancer

122 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Colorectal Cancer

512 trials tracked for Colorectal Cancer: 75 in phase 3 or 4 and 30 with published results. The most-cited published study has 1449 citations.

512Trials tracked
75Phase 3 & 4
0Recruiting
30With published results
Phase distribution
Phase 4 13 Phase 3 62 Phase 2 246 Phase 1 37 Other / NA 154
  1. Phase 3 Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Completed · 1,449 cited
  2. Phase 3 Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer Completed · 1,111 cited
  3. Phase 3 A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) Completed · 575 cited
  4. Phase 3 A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer Completed · 343 cited
  5. Phase 3 Adjuvant HIPEC in High Risk Colon Cancer Completed · 328 cited
  6. Phase 3 Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC Completed · 278 cited
Show 44 more trials
  1. Phase 3 Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia Completed · 262 cited
  2. Phase 3 A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients Completed · 260 cited
  3. Phase 3 Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Completed · 238 cited
  4. Phase 3 Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. Completed · 116 cited
  5. Phase 3 Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults Completed · 98 cited
  6. Phase 3 Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017) Completed · 88 cited
  7. Phase 3 Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy. Completed · 85 cited
  8. Phase 3 The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy Completed · 84 cited
  9. Phase 3 An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread Completed · 73 cited
  10. Phase 3 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Completed · 66 cited
  11. Phase 3 Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) Completed · 65 cited
  12. Phase 3 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Completed · 45 cited
  13. Phase 4 The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery Completed · 36 cited
  14. Phase 4 Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy Completed · 35 cited
  15. Phase 3 Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer Completed · 34 cited
  16. Phase 4 Comparative Efficacy of Water & Indigo Carmine vs. Water or Air Method on Adenoma Detection Rate (ADR) - a Randomized Controlled Trial (RCT) Completed · 31 cited
  17. Phase 4 Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Completed · 26 cited
  18. Phase 3 Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer Completed · 25 cited
  19. Phase 4 A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer Completed · 18 cited
  20. Phase 3 Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer Completed · 15 cited
  21. Phase 3 Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003) Completed · 14 cited
  22. Phase 3 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007) Completed · 12 cited
  23. Phase 3 S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 Completed · 3 cited
  24. Phase 3 Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults. Completed
  25. Phase 4 A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer Completed
  26. Phase 4 A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum Completed
  27. Phase 4 Patient Satisfaction With Propofol for Out Patient Colonoscopy Completed
  28. Phase 4 Glucagon Use in Colonoscopies Completed
  29. Phase 4 Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep Completed
  30. Phase 4 Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens Completed
  31. Phase 4 A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. Completed
  32. Phase 4 OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. Completed
  33. Phase 3 Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer Completed
  34. Phase 3 A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer Completed
  35. Phase 3 A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. Completed
  36. Phase 3 Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer Completed
  37. Phase 3 A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer Completed
  38. Phase 3 Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer Completed
  39. Phase 3 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study Completed
  40. Phase 3 Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection Completed
  41. Phase 3 A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer Completed
  42. Phase 3 BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy Completed
  43. Phase 3 Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery Completed
  44. Phase 3 Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine. Completed

Showing the 50 most-cited and recently-updated of 512 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Colorectal Cancer: what the trials found

Bupivacaine has been evaluated in clinical settings 13, and liposomal bupivacaine was shown to result in a post-operative pain score of 4 on the Visual Analog Scale 16. Indigo carmine is also established for use 15.

Regarding bowel preparation, studies compared various regimens; one study showed significant differences in the Boston Bowel Preparation Scale (BBPS) across different preparations (p<0.0001) 19. A trial comparing PEG-3350 and Gatorade found no significant difference in the Boston Prep Scale, sodium levels, or potassium levels 14.

In systemic therapy, oxaliplatin was evaluated where an association between Neutrophil to Lymphocyte Ratio (NLR) and progression-free survival (PFS) did not reach statistical significance (p=0.101) 17. 5-Fluorouracil was also studied, with a high rate of disease progression or death observed in the cohort 22.

Recent results — preliminary, needs further review

  • • Encorafenib showed significantly improved progression-free survival (PFS) compared to the control group across multiple assessment methods (p=0.0004; p<0.0001) 3. • Axitinib demonstrated a statistically significant improvement in overall survival (p=0.0021) and progression-free survival (p=0.0021) 5. • An exercise intervention was associated with significantly improved disease-free survival (p=0.02) and overall survival (p=0.02) 10. ․ Paclitaxel, EPO906, Nivolumab, temozolomide, Pembrolizumab, Colovac Colorectal Anastomosis Protection Device, Cologuard, and Median Ranked Cancer Screening Messaging were evaluated in recent trials but lacked specific outcome data or significant p-values in the provided summaries [1, 2, 4, 6, 7, 8, 9, 12].

For the clinician treating this condition

  • Encorafenib and Axitinib have shown statistically significant improvements in progression-free survival and overall survival respectively in recent phase 2 trials.
  • Exercise intervention has been associated with improved disease-free and overall survival outcomes.
  • Bowel preparation efficacy varies significantly between different protocols, while specific combinations like PEG-3350 and Gatorade showed no significant difference in prep scores or electrolyte levels.

AI synthesis of 10 cited trials, updated Aug 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Colorectal Cancer

Is robotic surgery safe for treating colorectal cancer and liver metastases together?

Yes, robotic surgery appears safe for treating colorectal cancer and liver metastases together in selected patients, with low conversion rates and no reported deaths in early studies.

Full answer →
How do specific mutations affect treatment response in Colorectal Cancer?

Specific mutations like KRAS, BRAF, and MMR status strongly influence treatment response in colorectal cancer, guiding targeted therapy and immunotherapy decisions.

Full answer →
What factors affect the quality of life for survivors of Colorectal Cancer?

Quality of life for colorectal cancer survivors is influenced by physical symptoms, psychological distress, social support, self-efficacy, and demographic factors like age and gender.

Full answer →
How does gut microbiota relate to the development of Colorectal Cancer?

Gut microbiota imbalances, including harmful bacteria like Fusobacterium nucleatum, can promote colorectal cancer through inflammation, DNA damage, and immune disruption, while beneficial microbes may offer protection.

Full answer →
What are the challenges of using artificial intelligence for Colorectal Cancer treatment?

AI in colorectal cancer treatment faces challenges including data quality and privacy issues, lack of generalizability, interpretability problems, and regulatory validation hurdles.

Full answer →
Can home exercise help reduce fatigue and anxiety in Colorectal Cancer patients?

Yes, home exercise may help reduce fatigue and anxiety in colorectal cancer patients, but the evidence is low certainty and more research is needed.

Full answer →
See all 6 questions about Colorectal Cancer →

All Colorectal Cancer Articles